Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links

Shalendra Singh; Praneet Vashishtha; Nipun Gupta; Ravi Wadke; Priya Taank

doi:10.5005/jp-journals-10071-23930

SEARCH WITHIN CONTENT

Online First

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links

Shalendra Singh, Praneet Vashishtha, Nipun Gupta, Ravi Wadke, Priya Taank

Keywords : COVID-19, Hydroxychloroquine, Intravenous immunoglobulin, Myasthenia gravis

Citation Information : Singh S, Vashishtha P, Gupta N, Wadke R, Taank P. Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links. Indian J Crit Care Med 2022; 26 (2):248-249.

DOI: 10.5005/jp-journals-10071-23930

License: CC BY-NC 4.0

Published Online: 09-02-2022

ARTICLE
REFERENCES

Abstract

HTML PDF Share

Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci 2020;414:116888. DOI: 10.1016/j.jns.2020.116888.
International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci 2020;412:116803. DOI: 10.1016/j.jns.2020.116803.
Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology 2020;94(22):959–969. DOI: 10.1212/WNL.0000000000009566.
Bonilla FA. Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysis. Clin Exp Immunol 2014;178 (Suppl. 1):72–74. DOI: 10.1111/cei.12518.

PDF Share